Blood test may predict chemo failure in aggressive breast cancer
Knowledge-focused
Recruiting now
This study looks at how well standard chemotherapy works in people with triple-negative breast cancer, an aggressive type that lacks targeted treatments. Researchers will also measure tiny molecules called microRNAs and tumor DNA in the blood to see if changes can signal when the…
Phase: PHASE2 • Sponsor: University College Hospital, Ibadan • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:30 UTC